Biosensors for the Detection of Circulating Tumour Cells

Sensors - Tập 14 Số 3 - Trang 4856-4875
Clotilde Costa1, Miguel Abal1, Rafael López‐López1, Laura Muinelo‐Romay2
1Translational Medical Oncology, Health Research Institute of Santiago (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), Trav. Choupana s/n 15706 Santiago de Compostela, Spain.
2Unity of CTCs analysis Translational Medical Oncology, Health Research Institute of Santiago (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (SERGAS), Trav. Choupana s/n 15706 Santiago de Compostela, Spain.

Tóm tắt

Metastasis is the cause of most cancer deaths. Circulating tumour cells (CTCs) are cells released from the primary tumour into the bloodstream that are considered the main promoters of metastasis. Therefore, these cells are targets for understanding tumour biology and improving clinical management of the disease. Several techniques have emerged in recent years to isolate, detect, and characterise CTCs. As CTCs are a rare event, their study requires multidisciplinary considerations of both biological and physical properties. In addition, as isolation of viable cells may give further insights into metastatic development, cell recovery must be done with minimal cell damage. The ideal system for CTCs analysis must include maximum efficiency of detection in real time. In this sense, new approaches used to enrich CTCs from clinical samples have provided an important improvement in cell recovery. However, this progress should be accompanied by more efficient strategies of cell quantification. A range of biosensor platforms are being introduced into the technology for CTCs quantification with promising results. This review provides an update on recent progress in CTCs identification using different approaches based on sensor signaling.

Từ khóa


Tài liệu tham khảo

Leemans, 1993, Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma, Cancer, 71, 452, 10.1002/1097-0142(19930115)71:2<452::AID-CNCR2820710228>3.0.CO;2-B

Nieuwenhuis, 2003, Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction, Lab Invest, 83, 1233, 10.1097/01.LAB.0000083532.46536.56

Dou, J., He, X., Liu, Y., Wang, Y., Zhao, F., Wang, X., Chen, D., Shi, F., and Wang, J. (2013). Effect of downregulation of ZEB1 on vimentin expression, tumor migration and tumorigenicity of melanoma B16F10 cells and CSCs. Cell Biol. Int.

Ensani, 2013, Improved detection of metastases by step sectioning and immuno-histochemical staining of axillary sentinel nodes in patients with breast carcinoma, Asian Pac. J. Cancer Prev., 14, 5731, 10.7314/APJCP.2013.14.10.5731

Li, 2013, The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer, Oncotarget, 4, 2532, 10.18632/oncotarget.1503

Vanharanta, 2013, Origins of metastatic traits, Cancer Cell, 24, 410, 10.1016/j.ccr.2013.09.007

Wang, 2014, Upregulation of the long non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage, Dig. Dis. Sci., 59, 591, 10.1007/s10620-013-2956-7

Cohen, 2008, Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer, J. Clin. Oncol., 26, 3213, 10.1200/JCO.2007.15.8923

Cristofanilli, 2004, Circulating tumor cells, disease progression, and survival in metastatic breast cancer, N. Engl. J. Med., 351, 781, 10.1056/NEJMoa040766

Scher, 2008, Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer, Clin. Cancer Res., 14, 6302, 10.1158/1078-0432.CCR-08-0872

Hou, 2009, Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy, Am. J. Pathol., 175, 808, 10.2353/ajpath.2009.090078

Krebs, 2010, Circulating tumour cells: Their utility in cancer management and predicting outcomes, Ther. Adv. Med. Oncol., 2, 351, 10.1177/1758834010378414

Punnoose, 2012, Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: Association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib, Clin. Cancer Res., 18, 2391, 10.1158/1078-0432.CCR-11-3148

Harouaka, 2014, Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications, Pharmacol. Ther., 141, 209, 10.1016/j.pharmthera.2013.10.004

Sun, 2011, Circulating tumor cells: Advances in detection methods, biological issues, and clinical relevance, J. Cancer Res. Clin. Oncol., 137, 1151, 10.1007/s00432-011-0988-y

Collings, A.F., and Caruso, F. (1997). Biosensors: Recent advances. Prog. Phys., 60.

Chambers, 2008, Biosensor recognition elements, Curr. Issues Mol. Biol., 10, 1

Chan, 2013, Evidence-based point-of-care diagnostics: Current status and emerging technologies, Annu. Rev. Anal. Chem. (Palo Alto Calif), 6, 191, 10.1146/annurev-anchem-062012-092641

Senveli, 2013, Biosensors in the small scale: Methods and technology trends, IET Nanobiotechnol., 7, 7, 10.1049/iet-nbt.2012.0005

Tweedie, 2006, Fabrication of impedimetric sensors for label-free point-of-care immunoassay cardiac marker systems, with passive microfluidic delivery, Conf. Proc. IEEE Eng. Med. Biol. Soc., 1, 4610, 10.1109/IEMBS.2006.260742

Vestergaard, 2007, An overview of label-free electrochemical protein sensors, Sensors, 7, 3442, 10.3390/s7123442

Hayes, 2006, Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival, Clin. Cancer Res., 12, 4218, 10.1158/1078-0432.CCR-05-2821

Cohen, 2006, Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer, Clin. Colorectal Cancer, 6, 125, 10.3816/CCC.2006.n.029

Cristofanilli, 2005, Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer, J. Clin. Oncol., 23, 1420, 10.1200/JCO.2005.08.140

Allard, 2004, Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases, Clin. Cancer Res., 10, 6897, 10.1158/1078-0432.CCR-04-0378

Budd, 2006, Circulating tumor cells versus imaging—Predicting overall survival in metastatic breast cancer, Clin. Cancer Res., 12, 6403, 10.1158/1078-0432.CCR-05-1769

Minguela, 2013, Imaging cytometry for counting circulating tumor cells: Comparative analysis of the CellSearch vs ImageStream systems, APMIS, 121, 1139, 10.1111/apm.12061

Watanabe, 2013, Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system, Cytometry A, 85, 206, 10.1002/cyto.a.22422

Earhart, 2013, Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips, Lab Chip, 14, 78, 10.1039/C3LC50580D

Earhart, 2009, Microfabricated magnetic sifter for high-throughput and high-gradient magnetic separation, J. Magn. Magn. Mater., 321, 1436, 10.1016/j.jmmm.2009.02.062

Mewes, 2012, A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire, Int. J. Oncol., 41, 1241

Vona, 2004, Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer, Hepatology, 39, 792, 10.1002/hep.20091

Vona, 2000, Isolation by size of epithelial tumor cells : A new method for the immunomorphological and molecular characterization of circulatingtumor cells, Am. J. Pathol., 156, 57, 10.1016/S0002-9440(10)64706-2

Farace, 2011, A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas, Br. J. Cancer, 105, 847, 10.1038/bjc.2011.294

Desitter, 2011, A new device for rapid isolation by size and characterization of rare circulating tumor cells, Anticancer Res., 31, 427

Xu, 2013, Three-dimensional telomeric analysis of isolated Circulating Tumor Cells (CTCs) defines CTC subpopulations, Transl. Oncol., 6, 51, 10.1593/tlo.12361

Zheng, 2007, Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells, J. Chromatogr. A, 1162, 154, 10.1016/j.chroma.2007.05.064

Zheng, 2011, 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood, Biomed. Microdevices, 13, 203, 10.1007/s10544-010-9485-3

Rosenberg, 2002, Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood, Cytometry, 49, 150, 10.1002/cyto.10161

Nagrath, 2007, Isolation of rare circulating tumour cells in cancer patients by microchip technology, Nature, 450, 1235, 10.1038/nature06385

Stott, 2010, Isolation of circulating tumor cells using a microvortex-generating herringbone-chip, Proc. Natl. Acad. Sci. USA, 107, 18392, 10.1073/pnas.1012539107

Adams, 2008, Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor, J. Am. Chem. Soc., 130, 8633, 10.1021/ja8015022

Wang, 2011, Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers, Angew. Chem. Int. Ed. Engl., 50, 3084, 10.1002/anie.201005853

Tan, 2009, Microdevice for the isolation and enumeration of cancer cells from blood, Biomed. Microdevices, 11, 883, 10.1007/s10544-009-9305-9

Tan, 2010, Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients, Biosens. Bioelectron., 26, 1701, 10.1016/j.bios.2010.07.054

Davis, 2006, Deterministic hydrodynamics: Taking blood apart, Proc. Natl. Acad. Sci. USA, 103, 14779, 10.1073/pnas.0605967103

Huang, 2004, Continuous particle separation through deterministic lateral displacement, Science, 304, 987, 10.1126/science.1094567

Inglis, 2006, Critical particle size for fractionation by deterministic lateral displacement, Lab Chip, 6, 655, 10.1039/b515371a

Alazzam, 2011, Interdigitated comb-like electrodes for continuous separation of malignant cells from blood using dielectrophoresis, Electrophoresis, 32, 1327, 10.1002/elps.201000625

Moon, 2011, Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP), Lab Chip, 11, 1118, 10.1039/c0lc00345j

Gascoyne, 2009, Isolation of rare cells from cell mixtures by dielectrophoresis, Electrophoresis, 30, 1388, 10.1002/elps.200800373

Hyun, 2013, Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients, Biosens. Bioelectron., 40, 206, 10.1016/j.bios.2012.07.021

Talasaz, 2009, Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device, Proc. Natl. Acad. Sci. USA, 106, 3970, 10.1073/pnas.0813188106

Powell, A.A., Talasaz, A.H., Zhang, H., Coram, M.A., Reddy, A., Deng, G., Telli, M.L., Advani, R.H., Carlson, R.W., and Mollick, J.A. (2012). Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One, 7.

Gleghorn, 2010, Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody, Lab Chip, 10, 27, 10.1039/B917959C

Shaffer, 2007, Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer, Clin. Cancer Res., 13, 2023, 10.1158/1078-0432.CCR-06-2701

Li, Y.M., Xu, S.C., Li, J., Han, K.Q., Pi, H.F., Zheng, L., Zuo, G.H., Huang, X.B., Li, H.Y., and Zhao, H.Z. (2013). Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease. Cell Death Dis., 4.

Pirozzi, 2013, Prognostic value of cancer stem cells, epithelial-mesenchymal transition and circulating tumor cells in lung cancer, Oncol. Rep., 29, 1763, 10.3892/or.2013.2294

Yu, 2013, Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition, Science, 339, 580, 10.1126/science.1228522

Barbazan, 2012, A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer, J. Cell. Mol. Med., 16, 2342, 10.1111/j.1582-4934.2012.01544.x

Barbazan, J., Alonso-Alconada, L., Muinelo-Romay, L., Vieito, M., Abalo, A., Alonso-Nocelo, M., Candamio, S., Gallardo, E., Fernandez, B., and Abdulkader, I. (2012). Molecular characterization of circulating tumor cells in human metastatic colorectal cancer. PLoS One, 7.

Galanzha, 2013, Circulating tumor cell detection and capture by photoacoustic flow cytometry in vivo and ex vivo, Cancers, 5, 1691, 10.3390/cancers5041691

Zharov, 2006, In vivo photoacoustic flow cytometry for monitoring of circulating single cancer cells and contrast agents, Opt. Lett., 31, 3623, 10.1364/OL.31.003623

Novak, 2004, In vivo flow cytometer for real-time detection and quantification of circulating cells, Opt. Lett., 29, 77, 10.1364/OL.29.000077

Thiery, 2002, Epithelial-mesenchymal transitions in tumour progression, Nat. Rev. Cancer, 2, 442, 10.1038/nrc822

Alonso-Alconada, L., Muinelo-Romay, L., Madissoo, K., Díaz-López, A., Krakstad, C., Trovik, J., Elisabeth, W., Hapangama, D., Coenegrachts, L., and Cano, A. (2013). Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. (submitted).

Benali, 2007, Circulating tumor cells (CTC) detection: Clinical impact and future directions, Cancer Lett., 253, 180, 10.1016/j.canlet.2006.12.014

Lin, 2010, Portable filter-based microdevice for detection and characterization of circulating tumor cells, Clin. Cancer Res., 16, 5011, 10.1158/1078-0432.CCR-10-1105

Dharmasiri, 2009, Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device, Electrophoresis, 30, 3289, 10.1002/elps.200900141

Dharmasiri, 2011, High-throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-abundance circulating tumor cells using a microfluidic system, Anal. Chem., 83, 2301, 10.1021/ac103172y

Saliba, 2010, Microfluidic sorting and multimodal typing of cancer cells in self-assembled magnetic arrays, Proc. Natl. Acad. Sci. USA, 107, 14524, 10.1073/pnas.1001515107

Smirnov, 2006, Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas, Cancer Res., 66, 2918, 10.1158/0008-5472.CAN-05-4003

Maheswaran, 2008, Detection of mutations in EGFR in circulating lung-cancer cells, N. Engl. J. Med., 359, 366, 10.1056/NEJMoa0800668

Sequist, 2009, The CTC-chip: An exciting new tool to detect circulating tumor cells in lung cancer patients, J. Thorac. Oncol., 4, 281, 10.1097/JTO.0b013e3181989565

Fracchiolla, 2013, Biosensors in clinical practice: Focus on oncohematology, Sensors, 13, 6423, 10.3390/s130506423

Tothill, I.E. (2003). Encyclopaedia of Food Sciences and Nutrition, Academic Press. [2nd ed.].

Kumar, 2013, Development of biosensors for the detection of biological warfare agents: Its issues and challenges, Sci. Prog., 96, 294, 10.3184/003685013X13777066241280

Zhang, 2013, Microfluidic beads-based immunosensor for sensitive detection of cancer biomarker proteins using multienzyme-nanoparticle amplification and quantum dots labels, Biosens. Bioelectron., 42, 23, 10.1016/j.bios.2012.10.076

Sioss, 2012, Nanoresonator chip-based RNA sensor strategy for detection of circulating tumor cells: response using PCA3 as a prostate cancer marker, Nanomedicine, 8, 1017, 10.1016/j.nano.2011.11.009

Moscovici, 2013, Rapid and specific electrochemical detection of prostate cancer cells using an aperture sensor array, Lab Chip, 13, 940, 10.1039/c2lc41049d

Kamande, 2013, Modular microsystem for the isolation, enumeration, and phenotyping of circulating tumor cells in patients with pancreatic cancer, Anal. Chem., 85, 9092, 10.1021/ac401720k

Issadore, D., Chung, J., Shao, H., Liong, M., Ghazani, A.A., Castro, C.M., Weissleder, R., and Lee, H. (2012). Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector. Sci. Transl. Med., 4.

Shao, N., Wickstrom, E., and Panchapakesan, B. (2008). Nanotube-antibody biosensor arrays for the detection of circulating breast cancer cells. Nanotechnology, 19.

Nedosekin, 2011, In vivo ultra-fast photoacoustic flow cytometry of circulating human melanoma cells using near-infrared high-pulse rate lasers, Cytometry A, 79, 825, 10.1002/cyto.a.21102

Kumeria, 2012, Label-free reflectometric interference microchip biosensor based on nanoporous alumina for detection of circulating tumour cells, Biosens. Bioelectron., 35, 167, 10.1016/j.bios.2012.02.038

2002, Aptasensors—The future of biosensing?, Anal. Bioanal. Chem., 372, 44, 10.1007/s00216-001-1189-3

Shamah, 2008, Complex target SELEX, Acc. Chem. Res., 41, 130, 10.1021/ar700142z

Wilson, 1999, In vitro selection of functional nucleic acids, Annu. Rev. Biochem., 68, 611, 10.1146/annurev.biochem.68.1.611

Andreescu, 2005, Advanced electrochemical sensors for cell cancer monitoring, Methods, 37, 84, 10.1016/j.ymeth.2005.05.007

Wang, 2006, Electrochemical biosensors: Towards point-of-care cancer diagnostics, Biosens. Bioelectron., 21, 1887, 10.1016/j.bios.2005.10.027

Soper, 2006, Point-of-care biosensor systems for cancer diagnostics/prognostics, Biosens. Bioelectron., 21, 1932, 10.1016/j.bios.2006.01.006

Bard, A.J., and Faulkner, L.R. (2001). Electrochemical Methods: Fundamentals and Applications, John Wiley and Sons, INC. [2nd ed.]. Chapter 1.

Wang, 1999, Amperometric biosensors for clinical and therapeutic drug monitoring: A review, J. Pharm. Biomed. Anal., 19, 47, 10.1016/S0731-7085(98)00056-9

Hassan, 2005, Novel potentiometric copper (II) selective membrane sensors based on cyclic tetrapeptide derivatives as neutral ionophores, Talanta, 66, 1034, 10.1016/j.talanta.2005.01.007

Hassan, 2003, New lead (II) selective membrane potentiometric sensors based on chiral 2,6-bis-pyridinecarboximide derivatives, Talanta, 60, 81, 10.1016/S0039-9140(03)00038-9

Jia, 2007, Label-free biosensor: A novel phage-modified light addressable potentiometric sensor system for cancer cell monitoring, Biosens. Bioelectron., 22, 3261, 10.1016/j.bios.2007.01.018

Katz, 2003, Probing biomolecular interactions at conductive and semiconductive surfaces by impedance spectroscopy: Routes to impedimetric immunosensors, DNA-Sensors, and enzyme biosensors, Electroanalysis, 15, 913, 10.1002/elan.200390114

Sadik, 2005, Impedance spectroscopy: A powerful tool for rapid biomolecular screening and cell culture monitoring, Electroanalysis, 17, 2101, 10.1002/elan.200503371

Prodromidis, 2010, Impedimetric immunosensors—A review, Electrochimica Acta, 55, 4227, 10.1016/j.electacta.2009.01.081

Choi, 2008, Ultra-sensitive surface plasmon resonance based immunosensor for prostate-specific antigen using gold nanoparticle—Antibody complex, Coll. Surf. A Physicochem. Eng. Asp., 313–314, 655, 10.1016/j.colsurfa.2007.05.057

Costa, 2009, Rapid identification and quantification of tumor cells using an electrocatalytic method based on gold nanoparticles, Anal. Chem., 81, 10268, 10.1021/ac902087k

Marx, 2003, Quartz crystal microbalance study of endothelial cell number dependent differences in initial adhesion and steady-state behavior: evidence for cell-cell cooperativity in initial adhesion and spreading, Biotechnol. Prog., 19, 987, 10.1021/bp0201096

Gammoudi, 2010, Love-wave bacteria-based sensor for the detection of heavy metal toxicity in liquid medium, Biosens. Bioelectron., 26, 1723, 10.1016/j.bios.2010.07.118

Uludag, 2012, Cancer biomarker detection in serum samples using surface plasmon resonance and quartz crystal microbalance sensors with nanoparticle signal amplification, Anal. Chem., 84, 5898, 10.1021/ac300278p

Mizutani, 2010, A novel FRET-based biosensor for the measurement of BCR-ABL activity and its response to drugs in living cells, Clin. Cancer Res., 16, 3964, 10.1158/1078-0432.CCR-10-0548

Esmaeilsabzali, 2013, Detection and isolation of circulating tumor cells: Principles and methods, Biotechnol. Adv., 31, 1063, 10.1016/j.biotechadv.2013.08.016

Germano, 2009, A portable and autonomous magnetic detection platform for biosensing, Sensors, 9, 4119, 10.3390/s90604119

Freitas, 2012, Spintronic platforms for biomedical applications, Lab Chip, 12, 546, 10.1039/C1LC20791A

Fernandes, 2014, A bacteriophage detection tool for viability assessment of Salmonella cells, Biosens. Bioelectron., 52, 239, 10.1016/j.bios.2013.08.053

Zhang, L., Ridgway, L.D., Wetzel, M.D., Ngo, J., Yin, W., Kumar, D., Goodman, J.C., Groves, M.D., and Marchetti, D. (2013). The identification and characterization of breast cancer CTCs competent for brain metastasis. Sci. Transl. Med., 5.